Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LYC-30937-EC for induction of remission in active ulcerative colitis
NL-OMON45977Phase 2Active, not recruiting
- Sponsor
- Lycera
- Start
- Feb 2017
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing LYC-30937-EC with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started Feb 2017; status: active, not recruiting.
02
Drugs
parimifasor
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on NL-OMON45977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45977.